
OpenEvidencerevenue, valuation & funding
Clinical Decision SupportCambridge, MassachusettsFounded 2021CEO Daniel Nadler
OpenEvidence is the leading medical information platform that offers an AI-powered platform organizing and expanding medical knowledge for clinicians, providing real-time, evidence-based answers.
OpenEvidence revenue
OpenEvidence's annual revenue was $100M in December 2025 (CNBC).
All 2 revenue readings, with sources
| As of | Revenue | Source |
|---|---|---|
| Jul 2025 | $50MEST | signalhub.substack.com estimate |
| Dec 2025 | $100M | CNBC |
OpenEvidence valuation
OpenEvidence is privately held, so there is no OpenEvidence stock to buy. Investors valued it at $12B in January 2026.
Valuation history$12B Series D 2026$6B Series C 2025$3.5B Series B 2025
OpenEvidence funding rounds & investors
OpenEvidence has raised $485M across four rounds since 2021. The latest was a $200M Series C in October 2025.
| Date | Round | Raised | Valuation | Source |
|---|---|---|---|---|
| Oct 2025 | Series C | $200M | $6B | – |
| Jul 2025 | Series B | $210M | $3.5B | finsmes.com |
| Feb 2025 | Series A | $70M | – | finsmes.com |
| Nov 2021 | Seed | $5M | – | clay.com |
| Total raised | $485M |
OpenEvidence CEO & employees
Daniel Nadler is CEO of OpenEvidence. OpenEvidence has 83 employees (November 2025, LinkedIn).
All 2 headcount readings, with sources
| As of | Employees | Source |
|---|---|---|
| Nov 2025 | 83 | |
| Sep 2025 | 55 |
OpenEvidence FAQ
What is OpenEvidence's revenue?
OpenEvidence's annual revenue was $100M in December 2025, according to CNBC.
What is OpenEvidence's valuation?
Investors valued OpenEvidence at $12B in January 2026, according to TechCrunch.
How much funding has OpenEvidence raised?
OpenEvidence has raised $485M across four funding rounds. The latest was a $200M Series C in October 2025.
Is OpenEvidence publicly traded?
No. OpenEvidence is a private company, so its shares aren't traded on a stock exchange.
How many employees does OpenEvidence have?
OpenEvidence has 83 employees as of November 2025, according to LinkedIn.
Who is the CEO of OpenEvidence?
Daniel Nadler is the CEO of OpenEvidence.
Browse Clinical Decision Support
How this page is sourced
6 from public sources · 1 estimate. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Nov 10, 2026Data disclaimerReport a correctionClaim this profileRun OpenEvidence? Join the podcast